Compare Davita Inc (DVA) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while iShares 10 20 Year Treasury Bond ETF trades at $96.55. The key difference: Davita Inc is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| DVA | TLH | |
|---|---|---|
Market Cap | $11.72B | — |
Sector | Health | Fixed Income |
52-Week High | $240.96 | $105.36 |
52-Week Low | $103.87 | $96.39 |
Enterprise Value | $24.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
TLH trades at $97.05 with minimal daily movement (+0.23%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock maintains consistent dividend payments, with recent payouts of $0.41, $0.36, and $0.38 per share. Market sentiment reflects broader bond market concerns as Treasury yields rise amid inflation uncertainty and geopolitical tensions.
The outlook remains cautious with bearish technical indicators dominating and macroeconomic pressures from rising interest rates. Dividend stability provides some support, but the stock faces headwinds from bond market volatility and inflation concerns that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
